CNSP CNS Pharmaceuticals, Inc.
$5.84▲ +1.57%
Healthcare
Other
After hours
$5.78▼ -1.03%
Sep 11, 7:30 PM ET
Volume 18.6K
Avg Volume (10D) 5.9K
Key Metrics & Fundamentals
Market Cap
$8.53M
P/E Ratio
–
Div Yield
–%
52W Range
1.90 - 10.59
% vs 50 MA
7.35%
% vs 200 MA
21.27%
RSI-14
54.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.08
Free Cash Flow
-$3.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.57M
COGS
–
Operating Exp
$2.70M
Operating Income
-$2.70M
EBIT
-$2.70M
Pretax Income
-$2.59M
Net Income
-$2.59M
EPS (Diluted)
-0.38
Price & Volume History
Loading chart…
Recent News
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
ACCESS Newswire · Sep 1, 2026 1:01 PM
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
ACCESS Newswire · Aug 27, 2026 1:01 PM
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
ACCESS Newswire · Aug 12, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNSP's money flow as a full page
Social Sentiment
No Reddit posts found for CNSP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.